Mirova’s Biogen BIIB Stock Holding History

Mirova’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-327	Closed	-$70.5K	–	127
2024 Q1	$70.5K	Hold	327	–	–	0.01%	127
2023 Q4	$84.6K	Sell	327 -19	-5%	-$4.67K	0.02%	107
2023 Q3	$88.9K	Sell	346 -492	-59%	-$132K	0.02%	106
2023 Q2	$239K	Sell	838 -853	-50%	-$254K	0.04%	117
2023 Q1	$470K	Sell	1,691 -1,971	-54%	-$545K	0.07%	113
2022 Q4	$1.01M	Buy	3,662 +695	+23%	+$196K	0.16%	86
2022 Q3	$792K	Buy	2,967 +141	+5%	+$29.9K	0.13%	95
2022 Q2	$576K	Buy	+2,826	New	+$578K	0.08%	125
2021 Q4	–	Sell	-545	Closed	-$154K	–	180
2021 Q3	$154K	Buy	545 +48	+10%	+$15.7K	0.02%	157
2021 Q2	$172K	Hold	497	–	–	0.02%	150
2021 Q1	$139K	Buy	497 +81	+19%	+$21.8K	0.02%	155
2020 Q4	$101K	Buy	416 +267	+179%	+$68.9K	0.01%	151
2020 Q3	$42K	Buy	149 +111	+292%	+$31K	0.01%	136
2020 Q2	$10K	Hold	38	–	–	﹤0.01%	154
2020 Q1	$12K	Hold	38	–	–	﹤0.01%	141
2019 Q4	$11K	Buy	+38	New	+$10.5K	﹤0.01%	159

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mirova's BIIB Position: Q2 2024 in Review

Mirova sold out of Biogen (BIIB) in Q2 2024, closing a stake of 327 shares — an estimated $70.5K sold.

Mirova first reported a position in BIIB in Q4 2019 and held it in 16 quarters. The position peaked at $1.01M in Q4 2022. 944 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

Mirova reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
Mirova sold 327 Biogen shares in Q2 2024, an estimated $70.5K.
Mirova first reported a position in Biogen in Q4 2019 and held it in 16 quarters.
Mirova's Biogen position peaked at $1.01M in Q4 2022.
944 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Mirova's 13F filing for Q2 2024, filed 13 Aug 2024.